Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1

Summary

The purpose of this study is to determine the efficacy and safety of a buprenorphine/naloxone sublingual tablet formulation as an office-based therapy for opiate-dependence treatment. The developmental objective for this combination product is an expansion of therapeutic options for the treatment of opiate dependence.

Timeline

Start

1996-11

Primary completion

1996-12

Completion

1997-01

Drugs

Indications